Proteomics and peritoneal dialysis: Early days but clear potential

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 1749-1753

  Brewis, Ian A ^a   Topley, Nicholas ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Biomarker; Dialysis; Peritoneal fluid; Proteomics

Indexed keywords

ADIPOCYTOKINE; ALPHA 2 MACROGLOBULIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C4A; GELSOLIN; HAPTOGLOBIN; IMMUNOGLOBULIN KAPPA CHAIN; INTELECTIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

DIALYSATE LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; NOTE; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; SEPSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ASCITIC FLUID; BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; PERITONEAL DIALYSIS; PROTEIN ARRAY ANALYSIS; PROTEIN INTERACTION MAPPING; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 77953006033     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq145     Document Type: Note

References (21)

1. Wang HY, Tian YF, Chien CC et al. Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal di-alysate. Nephrol Dial Transplant 2010; 25: 1955-1963
2. Cox J, Mann M. Is proteomics the new genomics? Cell 2007; 130: 395-398
3. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1: 845-867
4. Muller GA, Muller CA, Dihazi H. Clinical proteomics\on the long way from bench to bedside? Nephrol Dial Transplant 2007; 22: 1297-1300
5. Thongboonkerd V. Current status of renal and urinary proteomics: ready for routine clinical application? Nephrol Dial Transplant 2010; 25: 11-16
6. Lewczuk P, Wiltfang J. Neurochemical dementia diagnostics: state of the art and research perspectives. Proteomics 2008; 8: 1292-1301
7. Tyan Y, Liao P. Protoemics analysis of serous fluid and effusions: pleural, pericardial and peritoneal. Proteomics Clin Appl 2007; 1: 834-844
8. Ferrero S, Gillott DJ, Remorgida V et al. Proteomic analysis of peritoneal fluid in women with endometriosis. J Proteome Res 2007; 6: 3402-3411
9. Davidson B, Espina V, Steinberg SM et al. Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res 2006; 12: 791-799
10. Raaijmakers R, Pluk W, Schroder CH et al. Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis. Nephrol Dial Transplant 2008; 23: 2402-2405
11. Lin WT, Tsai CC, Chen CY et al. Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis. Ren Fail 2008; 30: 772-777
12. Sritippayawan S, Chiangjong W, Semangoen T et al. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes. J Proteome Res 2007; 6: 4356-4362
13. Thongboonkerd V. Proteomics in extracorporeal blood purification and peritoneal dialysis. J Proteomics 2010; 73: 521-526
14. Dihazi H, Muller CA, Matttes H et al. Proteomic analysis to improve adequacy of hemo-and peritoneal dialysis: removal of small and high molecular weight proteins with high-and low-flux filters or a peritoneal membrane. Proteomics Clin Appl 2008; 2: 1167-1182
15. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
16. Lilley KS, Friedman DB. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev Proteomics 2004; 1: 401-409
17. Zieske LR. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 2006; 57: 1501-1508
18. Unwin RD, Evans CA, Whetton AD. Relative quantification in pro-teomics: new approaches for biochemistry. Trends Biochem Sci 2006; 31: 473-484
19. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science 2006; 312: 212-217
20. Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrom-etry: approaches, advances, and applications. Annu Rev Biomed Eng 2009; 11: 49-79
21. Poon TC. Opportunities and limitations of SELDI-TOF-MS in bio-medical research: practical advices. Expert Rev Proteomics 2007; 4: 51-65